Short answer
SHOULDER INNOVATIONS, INC. (SI) filed an 8-K current report with the SEC on April 27, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Full commercial launch of InSet™ I-135RFX Humeral Stem announced April 27, 2026.
SHOULDER INNOVATIONS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Full commercial launch of InSet™ I-135RFX Humeral Stem announced April 27, 2026
- Product launch expands Shoulder Innovations’ commercial offering in shoulder arthroplasty
- Press release details furnished in Exhibit 99.1 for investor review
- Disclosure furnished under Regulation FD, limiting Section 18 liability and automatic filing incorporation
Item EX-99.1 · Exhibit EX-99.1
- Full commercial launch of InSet I-135RFX follows successful limited release and expanded FDA 510(k) clearance
- Product now supports primary, revision, and fracture total shoulder arthroplasty procedures
- Third I-Series humeral stem addition in three years, expanding SI’s shoulder implant portfolio
- Broader indications increase addressable surgeon use across anatomic and reverse shoulder procedures
- Integration with SI’s two-tray instrumentation system supports procedural simplicity and commercial adoption
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SHOULDER INNOVATIONS, INC. 8-K filings
Get the next SI 8-K as it lands
Follow SI for push alerts, or ask the research agent what this filing means.